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There is accruing evidence of cerebellar abnormalities in schizophrenia. The theory of
cognitive dysmetria considers cerebellar dysfunction a key component of schizophre-
nia. Delay eyeblink conditioning (EBC), a cerebellar-dependent translational probe, is
a behavioral index of cerebellar integrity. The circuitry underlying EBC has been well
characterized by non-human animal research, revealing the cerebellum as the essential
circuitry for the associative learning instantiated by this task. However, there have been
persistent inconsistencies in EBC findings in schizophrenia. This article thoroughly reviews
published studies investigating EBC in schizophrenia, with an emphasis on possible
effects of antipsychotic medication and stimulus and analysis parameters on reports of
EBC performance in schizophrenia. Results indicate a consistent finding of impaired EBC
performance in schizophrenia, as measured by decreased rates of conditioning, and that
medication or study design confounds do not account for this impairment. Results are
discussed within the context of theoretical and neurochemical models of schizophrenia.
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INTRODUCTION
Growing empirical evidence suggests cerebellar abnormalities in schizophrenia. In terms of cere-
bellar morphology, imaging studies report reduced cerebellar volume in chronic (1–4), neuroleptic-
naïve (5), adolescent (6), first-episode (7–9), and childhood-onset (10) schizophrenia [for exceptions
see Ref. (11, 12)]. Postmortem studies have also found reduced size and density of Purkinje cells
in schizophrenia (13–15). In addition to structure, cerebellar function has also been reported
to be abnormal in schizophrenia. Functional neuroimaging studies report abnormal cerebellar
activation at rest (16–18) and during cognitive tasks [Ref. (19–21); see Ref. (22) for critical review]
in individuals with schizophrenia.
These structural and functional cerebellar abnormalities appear to have clinical and functional
implications in schizophrenia. Specifically, cerebellar abnormalities are associated with clinical
symptoms, cognitive deficits, and outcome measures in schizophrenia (3, 23–25). For example,
deficits in working memory andmental flexibility correlate with cerebellar volume (26), and fronto-
cerebellar metabolic abnormalities are associated with anhedonia and ambivalence (27). Moreover,
increased connectivity between frontal–parietal and cerebellar regions predicts better cognitive
performance in controls and individuals with schizophrenia, and individuals with schizophrenia
with improved connectivity have fewer disorganization symptoms (28).
These empirical findings are often integrated into the cognitive dysmetria theory of
schizophrenia, which places the cerebellum prominently in the cortico-cerebellar-thalamic-cortical
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circuit (CCTCC). The theory of cognitive dysmetria proposes a
model of schizophrenia wherein deficits in this circuit are associ-
ated with both motor dysfunction and the clinical presentation of
schizophrenia, and abnormalities in the CCTCC are believed to
mediate the disordered cognition, behavior, and motor function
characteristic of individuals with schizophrenia (29). A behavioral
measure of cerebellar integrity, such as eyeblink conditioning
(EBC), that can be administered to individuals with schizophrenia
as an index of how well the cerebellum and interrelated circuits
are performing is vital to the investigation of the cerebellum as
a critical node in the CCTCC and locus of dysfunction in this
influential theory of schizophrenia.
Eyeblink conditioning is a widely used measure of cerebellar-
dependent associative learning. In the delay form of this task,
a conditioned stimulus (e.g., brief tone) is paired, and co-
terminates, with an unconditioned stimulus (e.g., air puff to the
eye) that elicits an unconditioned response (e.g., eyeblink). Over
the course of repeated paired presentations, a conditioned eye-
blink response (CR) occurs in response to the tone and preceding
the onset of the unconditioned stimulus. EBC is used in the
study of clinical disorders such as schizophrenia and autism as
well as aging for several reasons. First, the neural circuit under-
lying EBC has been well-characterized in non-human animals,
with the specific brain stem nuclei associated with both stimulus
encoding andmotor output remarkably well-understood [see Ref.
(30), for review]. Furthermore, the neural plasticity underlying
standard delay EBC has been localized to the ipsilateral dorsal
lateral anterior interpositus nucleus, and specific areas of the
cerebellar cortex involved with timing and gain control of the con-
ditioned response have also been identified [again see Ref. (30),
for review]. Second, the conditioned response that develops over
the course of delay EBC is well-preserved across species including
rodents [e.g., Ref. (31, 32)], rabbits [e.g., Ref. (33)], cats [e.g., Ref.
(34)], and humans [e.g., Ref. (35)], making EBC a widely used
translational probe of cerebellar function. Finally, the associative
learning induced by EBC is a non-declarative form of learning
that occurs outside of intention and conscious awareness (35).
Because performance on EBC is not dependent on higher-order
cognitive function or the ability to follow complex instructions, it
can be studied in individuals across a variety of ages and clinical
presentations.
Importantly, the robust identification of cerebellar circuitry
underlying delay EBC in non-human species is remarkably con-
sistent with human EBC findings. Such evidence has emerged
from studies involving patients with cerebellar lesions, dual-task
interference, transcranial direct current stimulation (tDCS), and
functional brain imaging. Specifically, individuals with cerebel-
lar strokes demonstrate impairments in delay EBC performance
(36–38). In addition, studies have demonstrated a significant
relationship between performance on delay EBC and cerebellar-
dependent timed interval tapping (39) aswell as dual-task interfer-
ence during simultaneous delay EBC and timed interval tapping
(40) in non-psychiatric controls. tDCS applied to the cerebellum
during acquisition has been shown to modify delay EBC perfor-
mance (41). Finally, human brain imaging studies investigating
the neural substrates of EBC converge with the lesion and dual-
task studies described above, as well as further localize the site of
EBC learning-related plasticity in humans. Specifically, positron
emission tomography (PET) studies have revealed changes in
cerebellar activation during EBC (42–46), and functional mag-
netic resonance imaging (fMRI) BOLD activation changes in the
cerebellum are consistently reported during EBC (47–50).
In the first published review of EBC studies and schizophre-
nia (51), the author concluded that overall the EBC find-
ings were inconclusive and any observed EBC deficits may
be accounted for by antipsychotic medication administration.
Lubow (51) called for an explicit comparison between med-
icated and non-medicated individuals with schizophrenia. In
addition, concerns were raised about drawing firm conclusions
regarding EBC impairment in schizophrenia due to inconsis-
tencies in the analysis of EBC (i.e., whether or not studies
accounted for alpha responses and spontaneous blink rate), pos-
sible group differences in processing and encoding EBC stimuli,
the notorious heterogeneity present in the diagnostic category of
schizophrenia, and the small sample sizes and disproportionate
number of male individuals with schizophrenia reported in the
literature (51).
Two subsequent brief reviews have appeared as subsections in
two recently published articles, one reviewing EBC performance
across many neurodevelopmental disorders (52) and another
reviewing cerebellar-related motor dysfunction in schizophrenia
and high-risk populations (53). The authors of both brief reviews
largely emphasized the emerging pattern of abnormal EBC per-
formance in schizophrenia, citing the large sample sizes and the
persistent deficit in EBC performance in an unmedicated sub-
sample reported in studies published after Lubow’s (51) review
(52), as well as even more recent studies of EBC impairment
in individuals with schizotypal personality disorder, first-degree
relatives of individuals with schizophrenia, and individuals with
schizophrenia who are medication-free for a period of several
weeks (53). However, both groups also acknowledged the possible
role of antipsychoticmedication andmethodological variability in
the inconsistent findings across studies (52, 53).
Importantly, since the publication of Lubow’s (51) initial review
of nine articles, six additional studies have been published exam-
ining EBC in the schizophrenia spectrum. These six studies
account for 48% of all individuals in the schizophrenia spec-
trum that have participated in delay EBC studies, nearly doubling
the number of participants in the schizophrenia spectrum that
have been studied since Lubow’s (51) review. However, questions
still persist regarding the source of inconsistency in the litera-
ture examining EBC in schizophrenia, specifically related to the
potential effects of antipsychotic medication and heterogeneity in
methodology.
The purpose of the present review was to conduct a thor-
ough and integrative review of published studies of EBC in the
schizophrenia spectrum. Given Lubow’s (51) findings and cau-
tions as well as the conclusions of Reeb-Sutherland and Fox (52)
and Bernard and Mittal (53), special attention was paid to (1)
evidence of antipsychotic medication effects, (2) inconsistencies
between studies in and any systematic effects of stimulus and
analysis parameters, and (3) differences in sample size and sample
characteristics. Finally, the findings of this review are interpreted
within the context of existing models of schizophrenia.
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METHOD
Tables 1–5 catalog 15 studies examining EBC in individuals with
schizophrenia. These studies were first identified using Lubow’s
existing review of EBC in schizophrenia. Studies examining EBC
in the schizophrenia spectrum published subsequent to this
review were identified using PubMed, a resource of the National
Center for Biotechnology Information (NCBI), at the National
Institutes of Health’s (NIH) U.S. National Library of Medicine
(NLM).
Various domains of information from these 15 studies exam-
ining EBC in the schizophrenia spectrum were then recorded
and organized, including sample characteristics (see Table 1),
parametric properties of the EBC tasks and analyses, and major
findings (see Tables 2–5). In the review of this literature, careful
attention was paid to (1) findings that occur consistently across
studies and across research groups, (2) the relationship of medica-
tion status to consistent findings, (3) any sample characteristics or
parametric variability (in either EBC paradigms or analyses) that
may contribute to heterogeneity of findings, (4) correlates of EBC
performance in individuals along the schizophrenia spectrum,
and (5) the implications of the findings of this review for current
systems-level and neurobiological theories of schizophrenia.
RESULTS
Conditioning
Conditioned Responding (e.g., %CRs)
Of the 15 studies of delay EBC in schizophrenia, 9 demonstrated
decreased CRs compared to controls (58, 61–68), 4 found no
group differences in rates of conditioned responding (54, 55, 59,
60), and 2 reported facilitated conditioning in schizophrenia (56,
57). It should be noted, however, in one study (56) which reported
overall increased percent CRs in schizophrenia vs. controls, that
when the auditory and visual EBC results are considered sepa-
rately, schizophrenia patients yielded fewer CRs when the CS was
an auditory vs. visual stimulus.
CR Onset Latency
One study reported shorter CR onset latencies in individuals with
schizophrenia vs. controls (61). Two studies reported longer CR
onset latencies in schizophrenia vs. controls (60, 64). Two studies
reported no significant differences between groups (66, 67). One
study reported blink onset latency results regardless of CR or UR
performance, and therefore cannot be considered with either CR
or UR results [see Ref. (57) in Table 5 for these and CS-alone
latency findings].
CR Peak Latency
Three studies reported shorter peak latency in individuals with
schizophrenia vs. controls (61, 63, 66). One study reported longer
CR peak latency in schizophrenia vs. controls (60), and three stud-
ies reported no significant differences between groups (62, 64, 65).
CR Amplitude
Five studies reported no significant differences between groups for
CR peak amplitude (60, 61, 63, 66, 67). Sears and colleagues (57)
reported increased CR amplitude in individuals with schizophre-
nia vs. controls inCS-alone trials. In post hoc analyses of individual
blocks, Forsyth and colleagues (65) found increased CR ampli-
tudes in controls vs. schizophrenia and SPD in later but not earlier
blocks of conditioning.
Medication Effects
Of the 15 published studies, 13 reported medication status and
all but one of these (56) included information specific to antipsy-
chotic medication status. In 10 of these 12 studies, most partici-
pants in the schizophrenia sample were currently taking antipsy-
chotic medication. In terms of conditioning effects, 8 of these 10
studies of medicated individuals reported decreased conditioning
(e.g., decreased percent CRs) in individuals with schizophrenia
compared to controls (58, 61–65, 67, 68). In the other two studies
of medicated individuals, no group differences in conditioning
rates were found (59, 60).
In 2 of the 12 studies, the entire schizophrenia group was
antipsychotic-free for 3weeks (57, 66). Sears and colleagues (57)
reported facilitated conditioning in these participants, whereas
Parker and colleagues (66) reported impaired conditioning. In
addition, 3 of the 12 studies analyzed data from antipsychotic-free
subsamples of individuals with schizophrenia (63, 64, 68). When
Bolbecker and colleagues (63) re-analyzed their data including
only the medication-free subset of individuals with schizophrenia
and their age-matched controls (with a sample size in each group
of n= 13, similar to other stand-alone studies of antipsychotic-
free schizophrenia), they found decreased CRs and shorter CR
peak latencies in these individuals with schizophrenia – with
even larger effect sizes than in the full sample of individuals with
schizophrenia. The authors reported no significant correlations
between EBC dependent variables and chlorpromazine equivalent
dosages (63), as did Brown and colleagues (61). Similarly, in a
later study, Bolbecker and colleagues (64) reported no significant
differences between schizophrenia participants medicated with
antipsychotics vs. those who were medication-free. Finally, Coes-
mans and colleagues (68) reported no effect of group on percent
CRs or “learning index” (change in number of CRs from first
to last conditioning block) when comparing the three subgroups
of individuals with schizophrenia (those taking atypical antipsy-
chotics, typical antipsychotics, and those who were antipsychotic
medication-free), and no significant correlation between learning
index and chlorpromazine equivalent dosages.
Finally, both studies including intermediate schizophrenia
spectrum participants [individuals with SPD (65) and first-degree
relatives (67)] reported that there was no antipsychotic use in
either of these populations. In these studies both individuals with
SPD and first-degree relatives of individuals with schizophrenia
were impaired in EBC.
Unconditioned Responses
UR measures on paired trials are reported less frequently in the
literature. With regard to percentage of URs, one study reported
decreased percent URs in individuals with schizophrenia vs.
controls (60). With regard to UR latency, two studies reported
slower UR peak latency in individuals with schizophrenia vs.
Frontiers in Psychiatry | www.frontiersin.org December 2015 | Volume 6 | Article 1463
Kent et al. Eyeblink Conditioning in Schizophrenia Review
TABLE 1 | Sample characteristics for studies of EBC in schizophrenia.
Study Samples Diagnosis Age
matched?
Antipsychotic medication
status (SZ spectrum groups)a
N Age % Male
Taylor and Spence
(54)
42 N/A N/A “Psychotic” No N/A
74 N/A N/A “Neurotic”
O’Connor and
Rawnsley (55)
20 47.2 (4.94) 100 Paranoid SZ No N/A
20 41.5 (5.84) 100 Non-paranoid SZ
20 39.4 (12.51) 100 Control
Spain (56) 54 40.6 59.3 Schizophrenia No All but 10 “were receiving some form of
drug treatment”24 N/A 50 Control
Sears et al. (57) 15 32.8 (9.8) 73.3 DSM-IV schizophrenia No Unmedicated for 3weeks
15 31.3 (7.2) 73.3 Control
Hofer et al. (58) 24 30.3 (9.0) 87.5 DSM-IV schizophrenia Yes 18 participants on atypical
antipsychotics, 6 on typical
antipsychotics
20 30.9 (8.9) 85 Control
Stevens et al. (59) 25 28.8 (6.5) 56 DSM-IV schizophrenia Yes Treated 14days with stable dose of
olanzapine
25 31.1 (6.8) 56 DSM-IV schizophrenia Taking stable dose of “classic
neuroleptics” 14days25 27.3 (5.6) 52 Control
Marenco et al. (60)
Trace 10 31.8 (8.7) N/A DSM-IV schizophrenia or
schizoaffective disorder
Yes
(3 years)
2 participants unmedicated for
3weeks; others taking antipsychotics
10 33.7 (7.7) N/A Control
Delay 10 41.8 (9.7) N/A DSM-IV schizophrenia or
schizoaffective disorder
Yes
(3 years)
3 participants unmedicated for
3weeks; others taking antipsychotics
10 41.9 (9.4) N/A Control
Brown et al. (61) 13 42 (9.56) 53.8 DSM-IV schizophrenia or
schizoaffective disorder
Yes 9 participants on atypical
antipsychotics, 1 on typical, 3 on both
13 40.2 (9.0) 53.8 Control
Edwards et al. (62) 10 40 (6.77) 60 DSM-IV schizophrenia Yes 1 participant taking typical
antipsychotics, 2 taking atypical
antipsychotics, 1 taking both; 5
participants not taking antipsychotics
8 43.5 (6.2) 62.5 Control
Bolbecker et al. (63) 62 39.8 (9.54) 62.9 DSM-IV schizophrenia Yes
(2 years)
12 participants unmedicated, 34 on
atypical antipsychotics, 7 on typical, 9
on both
62 39.9 (9.99) 48.4 Control
Bolbecker et al. (64) 55 41.1 (11.1) 60 DSM-IV schizophrenia spectrum
disorders
Yes
(2 years)
13 unmedicated, 36 taking atypical
antipsychotics, 16 taking typical
antipsychotics55 40.9 (11.3) 47.3 Control
Forsyth et al. (65) 18 37.7 (9.43) 55.6 DSM-IV schizophrenia Yes 3 SZ not taking medication at time of
testing, 14 on antipsychotics; 3 SPD
taking antidepressants, others
unmedicated
18 38.1 (9.87) 55.6 DSM-IV SPD
18 37.9 (9.85) 55.6 Control
Parker et al. (66) 20 28.2 (9.24) 61.1 DSM-IV schizophrenia No 5 neuroleptic-naïve, all others
medication-free for 3weeks20 29.2 (9.22) 50 Control
Bolbecker et al. (67) 18 36 (12) 72.2 DSM-IV schizophrenia or
schizoaffective disorder
Yes
(3 years)
for each triad
2 SZ unmedicated, 13 taking atypical
antipsychotics, 3 taking typical
antipsychotics; 2 relatives taking
antidepressants, others unmedicated
18 35.9 (13) 38.9 Confirmed first-degree relative
18 36.8 (13) 44.4 Control
Coesmans et al.
(68)
38 23.9 (range=18–35) 100 DSM-IV schizophrenia Yes 13 antipsychotic-free (6
antipsychotic-naïve, 7
antipsychotic-free for 4weeks), 9
taking atypical antipsychotics, 16 taking
typical antipsychotics
26 24.6 (range=18–31) N/A Control
aGiven the relevance of antipsychotic medication to motor abnormalities, we report here antipsychotic medication status specifically and not other psychotropic medications, except in
the case of intermediate spectrum participants.
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TABLE 2 | EBC paradigms and measurement techniques for studies of EBC
in schizophrenia.
Study Procedure type Method of eyeblink
activity measurement
Taylor and
Spence (54)
Single-cue visual delay
EBC
Microtorque potentiometer
mounted to lever attached to
upper eyelid and polygraph
recording eyelid position (69)
O’Connor and
Rawnsley (55)
Single-cue auditory
delay EBC
Light source and photoelectric cell
Spain (56) Combined visual and
auditory delay
(presented as 50 trials of
each, order
counterbalanced)
Auditory Auditory delay EBC Electrodes placed above and
below the eye; similar to
electrooculography
Visual Visual delay EBC Electrodes placed above and
below the eye; similar to
electrooculography
Sears et al. (57) Single-cue auditory
delay EBC
Infrared photobeam
Hofer et al. (58) Delay eyelid conditional
discrimination learning
Photocell that measured “area of
the eye covered by the eyelid” (via
“light reflected from the cornea”)
Stevens et al.
(59)
Discrimination auditory
delay EBC
–
Marenco et al.
(60)
Trace Single-cue auditory trace
EBC
“Potentiometer attached to the
eyelid”
Delay Single-cue auditory
delay EBC
“Potentiometer attached to the
eyelid”
Brown et al. (61) Single-cue auditory
delay EBC
EMG electrodes
Edwards et al.
(62)
Single-cue auditory
delay EBC
EMG electrodes
Bolbecker et al.
(63)
Single-cue auditory
delay EBC
EMG electrodes
Bolbecker et al.
(64)
ISI-shift single-cue
auditory delay EBC
EMG electrodes
Forsyth et al.
(65)
Single-cue auditory
delay EBC
EMG electrodes
Parker et al. (66) Single-cue auditory
delay EBC
Infrared photo beam
Bolbecker et al.
(67)
Single-cue auditory
delay EBC
EMG electrodes
Coesmans et al.
(68)
Single-cue auditory
delay EBC
Magnetic distance measurement
technique (i.e., measures distance
between upper eyelid and lower
eyelid)
controls (63, 64), while three other studies reported no signifi-
cant differences between groups (61, 65, 67). Finally, with regard
to UR amplitude, three studies reported increased UR ampli-
tude in schizophrenia vs. controls (63, 65, 67), whereas three
studies reported no significant group difference (61, 62, 64).
And, one study reported a significant group by block interaction
showing consistently diminished UR amplitude in individuals
with schizophrenia compared to controls, and larger initial UR
amplitude in controls that decreased across blocks (60).
Importantly, several studies explored group differences in URs
to unpaired unconditioned stimuli during pre-conditioning tri-
als or pseudoconditioning (prior to paired trial presentation).
Such pre-conditioning measures test for pre-existing differences
between groups in the ability to generate a blink in the absence
of recent associatively salient stimuli and habituation. Marenco
and colleagues (60) reported no group differences in baseline UR
activity; Edwards and colleagues (62) reportedno groupdifference
in baseline UR amplitude. Bolbecker and colleagues reported no
group differences in UR peak amplitude or latency in individuals
with schizophrenia compared to controls in one article (67) and
increasedUR amplitude in another (63) – in both cases suggesting
that conditioning deficits could not be accounted for by pre-
existing group differences in eyeblink responses. However, Sears
and colleagues (57) reported longerUR latency in individuals with
schizophrenia compared to controls for US-alone trials.
Extinction
Four studies reported no significant differences between extinc-
tion rate in individuals with schizophrenia and controls (60, 61,
63, 66). However, interpretation of this finding is complicated by
the group differences in percent CRs during the acquisition phase
reported by three of the studies (61, 63, 66). Finally, Brown and
colleagues (61) reported shorter CR onset and peak latency in
individuals with schizophrenia vs. controls during extinction.
Spontaneous Blink Rate
Several studies excluded individual trials in which a blink
occurred at a time during a trial that would render CR production
impossible (i.e., immediately prior to CS onset) [Ref. (61–65, 67);
see Ref. (60) for amore liberal window for trial exclusion].Most of
these studies also reported no significant group differences in this
rough estimate of spontaneous blink rate [Ref. (60, 63–65, 67), but
see Ref. (61)].
Alpha Responses
Three studies examined group differences in alpha responses,
which are reflexive orienting responses to the tone (importantly,
alpha responses are non-associative). All three studies reported
no group differences in the rate of alpha responses (57, 58, 60).
Marenco and colleagues (60) reported earlier onset of the alpha
response in controls vs. individuals with schizophrenia.
EBC Correlates
Symptoms and Demographic Variables
Multiple studies have failed to find significant relationships
between schizophrenia symptom severity and EBC dependent
variables (61, 63, 68). Brown and colleagues (61) and Bolbecker
and colleagues (63) also reported null results between symptom
severity and extinction dependent variables. Parker and colleagues
(66) found no significant correlations between positive or negative
symptoms and the three phases of conditioning the authors used
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TABLE 3 | EBC stimulus properties for studies of EBC in schizophrenia.
Study CS properties US properties
Auditory Visual US intensity (psi) US intensity
measurement
location
Dur.
(ms)
Modality Freq. (Hz) Intensity CS intensity
measurement
Dur. (ms) Modality Intensity CS intensity
measurement
Dur. (ms)
Taylor and Spence (54) – – – – – 6 cm milk
glass disk
24 Apparent
foot-candles
520 30mmHg= 0.58 psi Mercury manometer –
O’Connor and Rawnsley (55) Tone 1100 65 dB above
threshold for
each subject
800 – – – – 65mmHg= 1.26 psi N/A 500
Spain (56)
Auditory Tone 1000 60 “Decibels in
loudness”
1000 – – – – 1 g Measured at eye 160
Visual – – – – – Milk glass
disk
700 Millilamberts 1000 1g Measured at eye 160
Sears et al. (57) Tone 1000 75 dB 500 – – – – 5 N/A 100
Hofer et al. (58) Tone 1000 65 dB SPL 800 – – – – 4 N/A 80
Stevens et al. (59) Tone 300 80 dB SPL 800 – – – – 2 bar= 29psi N/A 100
Marenco et al. (60)
Trace Tone 1000 80 dB 500 – – – – Between 5 and 6 N/A 100
Delay Tone 1000 80 dB 500 – – – – Between 5 and 6 N/A 100
Brown et al. (61) Tone 1000 80 dB SPL 400 – – – – 10 At the source 50
Edwards et al. (62) Tone 1000 80 dB SPL 400 – – – – 10 At the source 50
Bolbecker et al. (63) Tone 1000 80 dB SPL 400 – – – – 10 At the source 50
Bolbecker et al. (64) Tone 1000 80 dB SPL 300; 400;
600; 900
– – – – 10 At the source 50
Forsyth et al. (65) Tone 1000 80 dB SPL 400 – – – – 10 At the source 50
Parker et al. (66) Tone 1000 75 dB 500 – – – – 5 N/A 100
Bolbecker et al. (67) Tone 1000 80 dB SPL 400 – – – – 10 At the source 50
Coesmans et al. (68) Tone 650 75 dB 520 – – – – Adapted to
minimum intensity
required to reliably
evoke a UR
N/A 20
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TABLE 4 | EBC experiment and analysis parameters for studies of EBC in schizophrenia.
Study Experiment parameters Dependent variable quantification criteria
ISI (ms) Mean
ITI (s)
Number
of blocks
Trials
per
block
Total trials
(no. of
blocks)
Total no.
paired
trials
Pre-conditioning
trials
Extinction trials CR criterion (amplitude) CR window
(post-CS latency ms)
Taylor and Spence
(54)
470 20 1 80 80 (1) 80 3 CS-alone,
1 US-alone
– 1mm deflection of eyelid closure
movement on polygraph (70)
200–470
O’Connor and
Rawnsley (55)
350 Random
b/t 20
and 40
1 48 48 (1) 30 3 CS-alone,
3 US-alone,
3 CS-alone
– On CS-alone trials (n= 18) only:
response amplitude 150% of maximum
baseline amplitude (when cue light turned
on before trial, 3–7 s pre-CS)
0–1.25 s post-CS
onset for CS-alone test
trials only
Spain (56)
Auditory 500 20ms 1 50 50 (1) 50 – – Non-voluntary eyelid movement 200–500
Visual 500 20ms 1 50 50 (1) 50 – – Non-voluntary eyelid movement 200–500
Sears et al. (57) 400 12 1 70 70 (1) 63 10 US-alone trials 40 unpaired CS or
US trials
Amplitude exceeds 10% of baseline UR
amplitude (measured from 10 US-alone
trials pre-conditioning) for paired and
CS-alone trials
200–400
Hofer et al. (58) 720 12 6 12 72 (6) 48 – – Change in the curve of eyelid data
waveform exceeds 0.4 cm for at least
30ms on S+ and S  trials (71)
390–720
Stevens et al. (59) 700 1100ms 1 70 70 (1) – – – – Eyeblink response
must occur 200–700
post-CS onset on S+
and S  trials
Marenco et al. (60)
Trace 1540 18 7 11 77 (7) 70 10 CS-alone and
10 US-alone
randomly presented
10 CS-alone and
10 US-alone
randomly presented
Eyelid movement 0.5mm for paired
and CS-alone trials
150–1540
Delay 440 18 7 11 77 (7) 70 10 CS-alone and
10 US-alone
randomly presented
10 CS-alone and
10 US-alone
randomly presented
Eyelid movement 0.5mm for paired
and CS-alone trials
150–440
Brown et al. (61) 350 15 10 10 100 (10) 90 8 US-alone trials 20 CS-alone and
20 US-alone
randomly presented
EMG amplitude over 5 SDs above pre-CS
125ms baseline for each paired trial
100–350
Edwards et al. (62) 350 15 10 10 100 (10) 90 8 US-alone trials – EMG amplitude over 5 SDs above pre-CS
225ms baseline for each paired trial
100–350
Bolbecker et al. (63) 350 15 10 10 100 (10) 90 8 US-alone trials 25 CS-alone and
25 US-alone
randomly presented
EMG amplitude over 5 SDs above pre-CS
125ms baseline for each paired trial
100–350
Bolbecker et al. (64) 250; 350;
550; 850
15 For each
ISI: 5
(total=10)
20 For each
ISI: 100 (5)
[total= 200
(10)]
For each
ISI: 90
(total= 180)
8 US-alone trials – EMG amplitude over 5 SDs above pre-CS
125ms baseline for each paired trial
150 pre-US onset
Forsyth et al. (65) 350 15 10 10 100 (10) 90 8 US-alone trials – EMG amplitude over 5 SDs above pre-CS
125ms baseline for each paired trial
100–350
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to analyze their EBC data (i.e., early, middle, and late); however,
negative symptoms were significantly correlated with late-phase
extinction of the CR. In the earliest examination of symptom
correlates of EBC, O’Connor and Rawnsley (55) reported no
significant correlation between EBC and introversion scores [but
see Spain (56) for EBC correlates of clinician-rated withdrawal].
Finally, in their investigation of demographic correlates of EBC,
Coesmans and colleagues (68) also reported non-significant cor-
relations between learning index and age and years of education.
Neuropsychological Variables
Bolbecker and colleagues (63) reported significant positive corre-
lations between average percent CRs and bothWASI IQ estimates
and the WASI Vocabulary subscale in controls, but not in indi-
viduals with schizophrenia. The Matrix Reasoning subscale was
not significantly correlated with average percent CRs in either
group. Forsyth and colleagues (65) reported a significant positive
correlation between percent CRs and Digit Symbol score (a sub-
scale of the WAIS) for schizophrenia spectrum participants (i.e.,
individuals with schizophrenia and SPD were combined into one
group). This significant correlation held when individuals with
schizophrenia were analyzed separately, but not when individu-
als with SPD were analyzed separately. Additionally, the authors
reported no significant correlations between Digit Symbol score
and percent CRs in controls, or between percent CRs and the
Picture Completion, Similarities, or Digit SpanWAIS subscales in
either controls or schizophrenia spectrumparticipants (65). Using
aggregate cognitive domain scores from a battery of neuropsy-
chological tests in patients, Parker and colleagues (66) reported
a significant positive relationship between both aggregate lan-
guage andmotor scores and CR timing during early conditioning;
motor scores were also correlated with middle-phase extinction
of the CR. Finally, Coesmans and colleagues (68) reported a
significant positive correlation between EBC learning index and
saccade adaptation strength in controls, but not individuals with
schizophrenia, while no significant correlations were found in
either group between EBC learning index and saccade adaptation
speed.
Neuroimaging Measures
In a study of cerebellar volumetric correlates of EBC, Edwards
and colleagues (62) reported a significant positive correlation
between anterior lobe volume and CR onset latency, and a sig-
nificant negative correlation between anterior lobe volume and
UR amplitude (in response to paired trials) in controls, but no
significant correlations between cerebellar MRI volume and EBC
dependent variables in individuals with schizophrenia. Parker
and colleagues (66) analyzed PET data according to phases of
conditioning (i.e., early, middle, and late), and reported decreased
rCBF in individuals with schizophrenia compared to controls in
frontal, thalamic, and cerebellar regions during both acquisition
and extinction (among other loci). In summarizing findings of
hypofrontality during EBC, the authors highlighted decreased
rCBF in individuals with schizophrenia compared to controls in
the contralateral medial frontal gyrus during all phases of condi-
tioning, and the contralateralmiddle frontal gyrus during the early
and middle phases of conditioning. The authors also highlighted
decreased rCBF in contralateral cerebellar lobules IV and V in
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TABLE 5 | Summary of main findings from studies of EBC in schizophrenia.
Study Summary of major findings
Taylor and
Spence (54)
CR – Trend for increased percent visual CRs in “psychotics” vs. “neurotics.”
O’Connor and
Rawnsley (55)
CR – No significant difference in number of CRs in response to CS-alone trials between groups (chronic paranoid SZ, chronic non-paranoid SZ,
control).
Extinction – Chronic paranoid SZ had significantly smaller “extinction scores” than controls.
Spain (56)
Auditory CR – Increased overall number of CRs in SZ vs. control, but effect not significant when examining subgroups matched for skin potential. SZ had
significantly more visual than auditory CRs; opposite relationship in HNs. CRs for auditory EBC fewer in SZ vs. HN (but no statistical test reported).
Visual CR – Increased overall number of CRs in SZ vs. control, but effect not significant when examining subgroups matched for skin potential. SZ had
significantly more visual than auditory CRs; opposite relationship in HNs. CRs for visual EBC greater in SZ vs. HN (but no statistical test reported).
Sears et al. (57) CR – SZ had significantly higher %CRs than controls and reached 70% CR learning criterion significantly faster (i.e., earlier in the experiment) than
controls. Significantly shorter onset latency of all blinks in SZ vs. controls during paired trials (however, difference is not significant when group
differences in conditioning level were accounted for and for CS-alone trials). CR amplitude significantly increased in SZ vs. controls in CS-alone
trials.
UR – Significantly longer UR latency in SZ vs. controls on US-alone trials.
Hofer et al. (58) CR – Trend for controls to develop first CR before SZ. No significant difference between S+ and S  in SZ; there was a significant difference in
controls for increased CRs to S+ vs. S . Significantly greater %CRs in controls vs. SZ for S+ but no significant difference for S . Significant group
x reinforcement type (S+ or S ) x block interaction indicated controls showed increased %CRs in response to S+ as the experiment progressed.
Stevens et al. (59) CR – No significant differences between groups in number of trials to reach learning “criterion” (i.e., 5 consecutive trials with an eyeblink response
<500ms pre-US onset to S+ but not S ).
Marenco et al. (60)
Trace CR – Analysis using the entire CR window appeared to be contaminated by spontaneous blinks (especially in SZ). A second analysis examining
when in the CR window responses occurred revealed that SZ demonstrated increased early conditioned responses vs. controls, and slightly fewer
later responses vs. controls. Frequency of early responses did not increase over time for SZ; control participants demonstrated trend-level
increases in early responses over time. No significant effects when examining the last 500ms as the CR window.
Delay CR – No group differences in %CRs. Longer CR onset and peak latency for SZ vs. controls in “conditioners” during paired trials and CS-alone
trials. More efficient “workratio” (a measure of CR efficiency of closing the eye at the time of US onset) in SZ vs. control “conditioners” during paired
trials and CS-alone trials.
UR – %URs significantly lower in SZ vs. controls in entire sample during paired trials. UR amplitude did not decrease across blocks in SZ vs.
control “conditioners” during paired trials. For CS-alone trials, %UR-range responses significantly decreased in SZ vs. controls for entire sample
(even larger effect when examining “conditioners” only).
Brown et al. (61) CR – Significantly fewer %CRs overall in SZ vs. controls, and a trend for controls acquiring more CRs over time than SZ. Significantly shorter CR
onset and peak latency in SZ vs. controls. Controls demonstrated decreased CR onset variability over time; SZ did not.
UR – Trend for longer UR peak latency in SZ vs. control.
Extinction – Significantly shorter CR onset and peak latency for SZ vs. controls.
Edwards et al. (62) CR – Marginally significant difference between groups in learning, as indexed by the difference between mean %CRs in the last two blocks and
mean %CRs in the first two blocks. Significantly higher %CRs in controls vs. SZ in block 9 of conditioning.
UR – No significant differences in UR peak amplitude for paired or unpaired trials. No significant correlation between unpaired UR peak amplitude
and mean CR amplitude.
Bolbecker et al. (63) CR – Significantly decreased %CRs and shorter CR peak latency in SZ vs. controls.
UR – Significantly slower UR peak latency in SZ vs. controls during paired trials. Significantly higher UR peak amplitude in SZ vs. controls for paired
and unpaired trials.
Extinction – Trend for fewer CRs during extinction for SZ vs. controls.
Bolbecker et al. (64) CR – Decreased %CRs in SZ vs. controls across ISIs and later (i.e., closer to US) CR onset latency in SZ vs. controls across ISIs.
UR – Significantly shorter UR latency in controls vs. SZ when first ISI presentation examined only (effect not significant when both first and second
ISI presentations are considered).
Forsyth et al. (65) CR – Decreased %CRs in SZ and SPD vs. controls, specifically in later blocks of conditioning. Trend for shorter CR peak latency in SZ and SPD vs.
controls. CR amplitudes larger in a few later blocks in controls vs. SPD and SZ.
UR – Significantly higher UR peak amplitude in SZ vs. controls and SPD.
Parker et al. (66) CR – Significantly greater %CRs in controls compared to SZ in middle and late phases of conditioning. CR peak latency significantly shorter in SZ
in middle phase of conditioning.
Bolbecker et al. (67) CR – Significantly lower rate of learning in SZ and relatives compared to controls. Controls increase in %CRs over time more than relatives and SZ.
UR – Larger UR amplitude during paired trials only in SZ vs. controls.
Coesmans et al. (68) CR – Significantly fewer %CRs in SZ compared to controls, with a trend-level group x block interaction. Controls demonstrated significantly higher
learning index (defined as the difference in first and last block number of CRs) vs. SZ.
SZ, individuals with schizophrenia; HN, healthy non-psychiatric controls; SPD, individuals with schizotypal personality disorder.
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individuals with schizophrenia compared to controls during all
phases of conditioning, with a group difference in ipsilateral cere-
bellar lobule VI during late acquisition only. Finally, group differ-
ences in rCBF in the thalamus were significant during early and
late conditioning. Regarding rCBF during extinction, the authors
highlighted decreased rCBF in individuals with schizophrenia
compared to controls during all phases of extinction in the medial
andmiddle frontal gyri and in cerebellar lobule IX. Additional loci
of decreased cerebellar rCBF in individuals with schizophrenia
compared to controls included cerebellar lobules IV and V during
middle extinction, and cerebellar lobules IV, V, and VI during
late extinction. Finally, the authors highlighted that decreased
thalamic rCBF in individuals with schizophrenia was significant
during early phase extinction (66).
DISCUSSION
Conditioning (i.e., %CRs)
In reviewing the literature investigating delay EBC in schizophre-
nia, decreased percent conditioned responses in individuals with
schizophrenia compared to non-psychiatric controls emerges as
the single consistent, robust, and replicated finding. Diminished
conditioning in schizophrenia is highly suggestive of cerebellar
dysfunction, given the crucial role of the cerebellum in the cir-
cuit underlying delay EBC. Moreover, as discussed in the fol-
lowing paragraphs, there are no extraneous variables (i.e., med-
ication status, sample size, different analytical approaches, para-
metric variability, non-associative blinking function, and inves-
tigative group) that could fully account for these EBC deficits in
schizophrenia.
In investigating the possible driving role of medication in the
observed EBC deficits (i.e., decreased %CRs) in individuals with
schizophrenia, it is crucial to note that both medicated and non-
medicated samples demonstrate conditioning deficits in individ-
uals with schizophrenia (see Medication Effects subsection of
Section “RESULTS”). Also important to this question of the effect
of antipsychotic medication on EBC are the findings of EBC
deficits in a non-medicated subsample (63), as well as the failure to
find group differences in medicated vs. unmedicated individuals
with schizophrenia (64, 68).
However, it is important to note that even the “medication-
free” samples and subsamples reported above are not medication-
naïve samples. While a small number of participants in the most
recent studies [n= 5 in Parker et al. (66), and n= 6 in Coes-
mans et al. (68)] were naïve to antipsychotics, the small sizes
of these groups precluded meaningful analyses investigating the
effect of antipsychotic-naïve medication status. Therefore, while
it appears unlikely based on the current review that recent use of
antipsychotic medication drives EBC deficits, it is impossible to
rule-out the long-term effects of antipsychotic use in individuals
with schizophrenia in the results of the study of “medication-free”
samples and subsamples.
Eyeblink conditioning studies of intermediate genotypes and
phenotypes of schizophrenia such as first-degree relatives (67)
and SPD (65) that have demonstrated conditioning deficits in
these groups are very important, especially given the absence
of studies using medication-naïve or first-episode schizophrenia
groups. Neither of these study groups were taking antipsychotic
medication. This suggests that EBC deficits are related to the
genetic/biological pathophysiology of schizophrenia, not the his-
tory of or current antipsychotic medication use.
In addition to medication status, examination of Tables 1–5
reveals no systematic sample characteristic, parameter, or analytic
approach that could be driving this review’s main finding of EBC
deficits in schizophrenia. Indeed, EBC deficits occur across sam-
ples of varying ages and gender composition, and in studies using
a range of EBC stimulus parameters and experimental design
(e.g., CS/US duration, ISI, ITI, and pre-conditioning trials or
pseudoconditioning) and analysis (e.g., CRwindow and criterion)
specifications. Furthermore, potentially confounding issues such
as spontaneous blink rate and baseline blinking function have
been investigated by several groups, with no convincing evidence
that these variables bias EBC experimental results.
Furthermore, it appears as though many studies reporting null
findings or facilitated conditioning may have parametric or ana-
lytic variations that could account for such results. Specifically,
Taylor and Spence (54) used a visual delay EBC paradigm, and
the diagnostic criteria for the disorder differed substantially from
those used in recent decades. Furthermore, the idiosyncratic ana-
lytic approaches of other studies may account for the reported
null findings. For example, rather than quantifying rate of con-
ditioning, Stevens and colleagues (59) measured the number of
trials it took for participants to reach “criterion,” or five consec-
utive CRs. This style of analysis is not reported in most other
studies. Another study appeared to restrict their analysis such
that relatively less data are included compared to other studies.
Specifically, O’Connor and Rawnsley (55) only used 18 unpaired
CS-alone trials tomeasure conditioning, rather than attempting to
detect CRs across all paired trials over the course of conditioning.
Finally, Sears and colleagues (57) did not include a measure of
spontaneous blink rate; it is therefore possible that group dif-
ferences in non-associative blinking could have confounded the
reported findings of facilitated conditioning in schizophrenia.
More research is necessary to determine whether these varied
findings are due to these methodological differences or, in fact,
reflect inconsistencies in EBC deficits in schizophrenia across
studies.
CR Timing
Group differences in timing of the conditioned response (i.e.,
onset and peak latency) have been reported far less frequently than
rate of conditioning (i.e., percent CRs). Among studies reporting
these variables, there is inconsistency in how onset latency is cal-
culated and whether the algorithm used to calculate onset latency
is reported. Results are also inconsistent, with findings reported
in both directions and null results. However, the proportion of
findings reporting some group difference (N = 7) in CR timing
vs. null results (N = 6) suggests that there may be abnormalities
in the timing of the conditioned response in individuals with
schizophrenia.
Interpretation of Correlate Findings
Parker and colleagues’ (66) findings of both impaired condi-
tioning and decreased cerebellar blood flow in individuals with
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schizophrenia compared to controls during delay EBC strongly
suggest that cerebellar neural dysfunction underlies the behav-
ioral EBC abnormalities consistently reported in individuals with
schizophrenia. This is a crucial piece of evidence, as authors
reporting previous findings of impaired delay EBC in individuals
with schizophrenia have inferred underlying cerebellar dysfunc-
tion given the well-established delay EBC cerebellar circuitry in
non-human animals.
In addition, EBC correlates of neuropsychological performance
are reported by a few studies (63, 65, 66). This shared variance
between cerebellar-dependent EBC performance and cognition
indicates that the cerebellum may be a shared neural substrate
between these two processes, which is consistent with cerebellar
involvement in cognitive as well as motor function.
Limitations and Future Directions
One critical conclusion from this review is that antipsychotic
medications do not appear to be driving the EBC deficit observed
consistently in schizophrenia. However, this conclusion is primar-
ily based on the study of EBC in unmedicated (rather than never-
medicated) individuals with schizophrenia, first-degree relatives
and individuals with schizotypal personality disorder. While the
robustness of the EBC deficit in these populations is obviously
compelling, a logical and important next step is conducting delay
EBC in first episode and/or never-medicated individuals. Second,
significant variability in methodological and analytic strategies
across EBC studies precluded ameta-analytic approach; therefore,
as more studies are conducted using consistent methods, statisti-
cal analyses, and reporting, this approach should be considered.
Third, further replication of the main findings of this review
article (i.e., an EBC deficit in schizophrenia) is essential given that
one investigative group has accounted for most patients studied (6
of 15 studies).
Finally, further work investigating the neural activity in the
cerebellum during delay EBC in schizophrenia is essential to
elucidating the specific contribution of the cerebellum in driving
impairments in delay EBC. Specifically, the fine-grained spatial
resolution of fMRI could prove essential to understanding which
regions of the cerebellum underlie delay EBC in humans, and
where this circuit is degraded in schizophrenia.
EBC Findings Within the Context of
Theories of Schizophrenia
Overall, the reported deficits in cerebellar-dependent EBC in
individuals with schizophrenia are consistent with the theory
of cognitive dysmetria, in which the cerebellum is one node in
a circuit regulating the fluid temporal coordination of motor,
cognitive, and affective information, the disruption of which is
hypothesized to be a common underlying precursor to the het-
erogeneous downstream expressions of the phenomenology of
schizophrenia (29, 73). The cerebellum is believed to play a unique
role in this circuit mediating the coordination (or instantiating
the discoordination) of mental activity, which also includes the
prefrontal cortex and the thalamus. Specifically, it is the feedback
(via the thalamus) between the prefrontal cortex (and the higher-
order cognitive processes instantiated therein) and the cerebellum
(which is notable for cytoarchitecture conducive to large-scale
parallel processing and its role in coordination, sequencing, and
timing) that is hypothesized to instantiate the fluid temporal
coordination of mental activity (29, 73). As stated above, con-
sistent deficits in performance on one of the most robust and
well-understood (with respect to underlying circuitry) cerebellar
tasks in individuals with schizophrenia provide evidence con-
sistent with the theory of cognitive dysmetria, and this finding
is germane to its arguably most critical node [Andreasen (29)
initially identified assays of cerebellar function, specifically citing
EBC as a potential example, as the litmus test through which
the theory can be falsified]. In addition, the relationship between
cerebellar function and cognitive function supports this theory
(63, 65, 66).
More specifically, the possible mechanisms of the cerebel-
lum’s contribution to higher-order cognitive function have been
hypothesized to parallel that proposed by control theory in the
domain of motor control [see Ref. (74, 75), for review]. The cere-
bellum is hypothesized to contribute to the coordination of move-
ment via internal models (both forward and reverse) (74), which
are neural representations that can be trained to simulate the
dynamics of motor action (74–76). Forward models are believed
to receive input that duplicates the motor command (termed an
efference copy) sent by the motor cortex (which controls move-
ment) after the motor cortex receives a higher-order instructor
command (i.e., from the premotor cortex), and output a predic-
tion of what the sensory consequences of that command will be (a
corollary discharge). The forwardmodel is tuned by a mechanism
that compares sensory predictions of the model to actual sensory
input, which has been hypothesized to occur in the inferior olive.
Once a forward model is adequately trained, it can provide useful
feedback (via the thalamus) to the primary motor cortex, which
executes motor commands (74, 75). An inversemodel, conversely,
can eventually conduct feed-forwardmotor control in response to
a higher-order instructor command.While error-related feedback
processing in the inferior olive is also hypothesized to tune inverse
models, inverse models are trained by comparing motor output
to the initial instructor command, and this feedback is mediated
through the motor cortex (74).
In generalizing the function of internal models in the cerebel-
lum to a role in cognition, it has been proposed that there are
areas in the prefrontal cortex (following a higher-order instructor
command, as in the example using motor function) that send
commands to areas of the cortex that instantiate psychological
processes and manipulate these areas in much the same way the
motor cortex manipulates the motor system. In this way, the
cerebellum receives an efference copy of this command and can
learn and execute forward models that would simulate processing
in the target brain area and provide feedback to the prefrontal
cortex (74, 75). Using an inverse model, the cerebellum could
actually perform feed-forward control of cognitive function (again
following an instructor signal) by acting directly on the target
brain area (74).
These putative mechanisms of cerebellar contributions to cog-
nition are supported by the frequently cited uniformity of cerebel-
lar cytoarchitecture, which, along with its circuitry suggest that
the cerebellum is performing a uniform process across a variety
of cortical inputs (74, 75). In addition, the matched increase in
both cerebral and cerebellar neurons in humans as well as high
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connectivity between the cortex and cerebellum also indicate the
proposedmechanisms of cerebellar contributions to cognition are
physiologically plausible (77, 78). Finally, translational evidence
in support of cerebellar contributions to cognition can be found
in comparing cortical projections to the cerebellum in humans
and macaque monkeys, where the largest proportion of the pro-
jections in humans originates in prefrontal cortex vs. motor areas
in macaque monkeys [see Ref. (75) for review]. In light of this
physiological and translational evidence, the proposed function
of internal models as a mechanism of cerebellar contributions
to cognition seems both anatomically and evolutionarily sound.
Ramnani (75) has further described internal models as ideally
suited to rapid, highly accurate, efficient processing of routine,
well-practiced cognitive processes, whereas cortical mechanisms
are best suited for flexible though less efficient processing, which
would be important for processing novel problems or generalizing
cognitive processes across different contexts.
In addition to being a robust assay of cerebellar function, EBC
is especially germane to the putative mechanisms outlined above
in light of the proposed mechanism of error correction of inter-
nal models. Specifically, the feedback-related tuning of internal
models is believed to be instantiated through error signals sent
from climbing fibers (originating in the inferior olive), which
results in LTD at the parallel fiber–Purkinje cell synapse when
climbing and parallel fibers are simultaneously activated (74).
In EBC, US information is transmitted through climbing fibers
from the inferior olive, and is often conceptualized as an error
signal, and an identical LTD mechanism as that described above
is believed to be an integral part of cerebellar cortical plasticity
during conditioning [see Ref. (79) for review]. It has previously
been suggested that dysfunctional internal models may be the
mechanism of cerebellar-mediated cognitive and affective dys-
function in schizophrenia (22, 74). It is therefore notable that the
findings of this review indicating deficits in cerebellar function
in schizophrenia, and more importantly EBC deficits specifically,
may be indicative of dysfunctional cerebellar internal models,
which may be mediating the cardinal cognitive and affective
symptoms of the disorder.
However, neuropsychological correlates of EBC in individuals
with schizophrenia have been rarely investigated. Furthermore,
the consistently reported non-significant correlations between
delay EBC and symptom severity in individuals with schizophre-
nia is surprising given the putative role of the cerebellum in the
pathophysiology of schizophrenia. It is possible that the con-
tributions of cerebellar deficits to the pathological processes of
schizophrenia are more proximal effects on timing and coordina-
tion of information, whereas symptoms and impaired neuropsy-
chological function are more distal manifestations of the disorder
that are affected by many factors and are not linearly related in
magnitude to cerebellar dysfunction. Restricted range in neu-
ropsychological and symptommeasures and/or floor effectsmight
also obscure any systematic relationships between these variables
and EBC performance. Finally, symptoms are a state-dependent
variable; the potentially transient and fluctuating nature of symp-
tom severitymight also account for the lack of reported correlates.
Alternatively, it is possible that cerebellar dysfunction in areas
outside of the delay EBC circuitry is related to symptom severity
and neuropsychological function. Still, more research is necessary
to understand the relationships between cerebellar-mediated dys-
function and cognitive and clinical variables.
Importantly, EBC performance deficits in schizophrenia may
have implications for glutamatergic models of the disorder given
that glutamate is the primary excitatory neurotransmitter in the
cerebellum [see Ref. (80) for review]. The glutamate model of
schizophrenia hypothesizes dysfunction of the NMDA type of
glutamate receptor [see Ref. (81) for overview]. Non-human ani-
mal research has implicated NMDA receptors in the interpositus
nucleus in CR acquisition [Ref. (82); see Ref. (79) for a thor-
ough review of the neural mechanisms of EBC]. Given that the
“memory trace” of delay EBC has been localized to the anterior
interpositus nucleus, it is therefore possible that impairments
in conditioning in schizophrenia (reported most frequently as a
decrease in percent CRs, or impaired CR acquisition) are related
to NMDA receptor dysfunction in the interpositus nucleus in
schizophrenia.
There is also substantial glutamatergic transmission in the cere-
bellar cortex; therefore, abnormalities in CR timing (largely medi-
ated by the cerebellar cortex) may also be indicative of NMDA
receptor dysfunction in schizophrenia. While NMDA receptors
have been reported in the cerebellar cortex (80), they were tradi-
tionally not believed to play a role in the cellular mechanism (i.e.,
LTD at the parallel fiber-Purkinje cell synapse following both par-
allel and climbing fiber input to Purkinje cells) believed to underlie
EBC-related learning in the cerebellar cortex [see Ref. (83) for
review]. Importantly, however, there is more recent evidence
that NMDA receptors at the climbing fiber–Purkinje cell synapse
may in fact contribute to LTD at the parallel fiber–Purkinje cell
synapse (84). Furthermore, more broad conceptualizations of the
substrates of cerebellar learning are emerging that suggest that
mechanisms of cerebellar cortical plasticity and neural activity
beyond LTD at the parallel fiber-Purkinje cell synapse (some
involving NMDA receptors) may be involved in EBC (85, 86).
Accordingly, more research is necessary to determine the role of
glutamate in reported EBC timing abnormalities in schizophrenia.
In addition to the glutamate hypothesis, abnormalities in
the endocannabinoid system in schizophrenia [see Ref. (87) for
brief review] are also implicated by the current review findings.
Edwards and Skosnik (87) have proposed EBC neural circuitry
including endocannabinoids as retrograde signals serving to neu-
romodulate cerebellar cortical activity, thereby influencing CR
timing and morphology. It is therefore possible that CR timing
abnormalities in schizophrenia are indicative of abnormalities in
the endocannabinoid system [see Ref. (87) for discussion].
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